Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2009 (Vol. 29, No. 1)

DAVID Bioinformatics Resources 2008

URL:david.abcc.ncifcrf.gov
  • Useful tools
  • Narrowly aimed at users
DAVID (database for annotation, visualization, and integrated discover) is yet another aim to provide tools for researchers to understand the meaning of data for large gene sets. Microarrays, of course, can easily overwhelm researchers with information, so putting it together is essential to enhance our under- standing of systems biology. DAVID allows researchers to discover function-related gene groups, display gene info in 2-D plots, link genes to disease, list interacting proteins, and view genes on pathway maps. Towards these ends, the site provides tools for functional annotations, gene function classification, gene ID conversion, and a gene name batch viewer. The site appears to be popular, with over 650 papers referencing it and over 1,200 uses per day. If you’re into genome-wide analysis of gene function, DAVID is worth at least a serious look at its contents.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »